These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 32196626)
21. The Microbiome: What Will the Future Hold? Monsour HP; Quigley EM Semin Liver Dis; 2016 Sep; 36(4):354-359. PubMed ID: 27997976 [TBL] [Abstract][Full Text] [Related]
22. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases. Li Y; Tang R; Leung PSC; Gershwin ME; Ma X Autoimmun Rev; 2017 Sep; 16(9):885-896. PubMed ID: 28698093 [TBL] [Abstract][Full Text] [Related]
23. Role of gut microbiota in liver disease. Albhaisi SAM; Bajaj JS; Sanyal AJ Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G84-G98. PubMed ID: 31657225 [TBL] [Abstract][Full Text] [Related]
24. [The human gut microbiota: Interactions with the host and dysfunctions]. Lepage P Rev Mal Respir; 2017 Dec; 34(10):1085-1090. PubMed ID: 28506730 [TBL] [Abstract][Full Text] [Related]
25. [Gut microbiota-an important contributor to liver diseases]. Wang F; Cui Q; Zeng Y; Chen P Nan Fang Yi Ke Da Xue Xue Bao; 2020 Apr; 40(4):595-600. PubMed ID: 32895142 [TBL] [Abstract][Full Text] [Related]
26. Gut microbiome and liver diseases. Tilg H; Cani PD; Mayer EA Gut; 2016 Dec; 65(12):2035-2044. PubMed ID: 27802157 [TBL] [Abstract][Full Text] [Related]
27. [The role of gut microbiota in chronic liver diseases, and treatment possibilities]. Hagymási K; Bacsárdi A; Egresi A; Berta E; Tulassay Z; Lengyel G Orv Hetil; 2018 Sep; 159(36):1465-1474. PubMed ID: 30175608 [TBL] [Abstract][Full Text] [Related]
28. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease? Brandl K; Schnabl B Expert Rev Gastroenterol Hepatol; 2015; 9(8):1069-76. PubMed ID: 26088524 [TBL] [Abstract][Full Text] [Related]
29. Introduction. Chen P Adv Exp Med Biol; 2020; 1238():1-10. PubMed ID: 32323176 [TBL] [Abstract][Full Text] [Related]
30. Microbiota, immunity and the liver. Vaikunthanathan T; Safinia N; Lombardi G; Lechler RI Immunol Lett; 2016 Mar; 171():36-49. PubMed ID: 26835593 [TBL] [Abstract][Full Text] [Related]
31. The fingerprint of the human gastrointestinal tract microbiota: a hypothesis of molecular mapping. Tomasello G; Mazzola M; Jurjus A; Cappello F; Carini F; Damiani P; Gerges Geagea A; Zeenny MN; Leone A J Biol Regul Homeost Agents; 2017; 31(1):245-249. PubMed ID: 28337900 [TBL] [Abstract][Full Text] [Related]
32. Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases. Binda C; Gibiino G; Coluccio C; Sbrancia M; Dajti E; Sinagra E; Capurso G; Sambri V; Cucchetti A; Ercolani G; Fabbri C Microorganisms; 2022 Jan; 10(2):. PubMed ID: 35208765 [TBL] [Abstract][Full Text] [Related]
33. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases. Chen B; Sun L; Zhang X J Autoimmun; 2017 Sep; 83():31-42. PubMed ID: 28342734 [TBL] [Abstract][Full Text] [Related]